Benefits of Attending & Past Statistics

Benefits of Attending & Past Statistics

Industry Benefits of Supporting ESID 2024:

  • Promotes cutting-edge scientific research
  • Contributes to the advancement of Primary Immunodeficiency (PID) on an international level
  • Offers a unique opportunity to exchange ideas with renowned professionals from across the world
  • Provides an ideal networking forum
  • Offers unique exposure to worldwide markets

ESID Attendance over the years

ESID 2018 (Lisbon) - 2,475 Participants
ESID 2019 (Brussels) - 1,669 Participants
ESID 2020 (Virtual) - 1,969 Participants
ESID 2021 (Virtual) - 1,090 Participants
ESID 2022 (Gothenburg & Online) - 2,075 Participants

Statistics from ESID 2022 – Gothenburg & Online

Total Registrations

Total Countries

Total Participants In-Person

Total Participants Online

PARTICIPANTS BY WORLD REGIONS

TOP 10 COUNTRIES

0

UNITED KINGDOM

0

SWEDEN

0

GERMANY

0

UNITED STATES

0

ITALY

0

NETHERLANDS

0

FRANCE

0

SPAIN

0

TURKEY

0

SWITZERLAND

PARTICIPANTS BY PROFESSIONAL ROLE

Clinical Practitioner
Clinician Researcher
Other
Industry/ Corporate Professional
Resident/Research Fellow
Basic Science Researcher
Student
Nurse/Healthcare Practitioner

PARTICIPANTS BY PROFESSIONAL INTEREST

Immunology
Pediatrics
Other
Allergy & Clinical Immunology
Internal Medicine
Molecular Biology
Hematology
Biochemistry
Pharmacology
Rheumatology

PARTICIPANTS BY AGE

0%

18 - 30

0%

30 - 40

0%

40 - 50

0%

50 - 60

0%

60+
   Visit 2022 website    Become a member